Header Logo

Connection

DEBANANDA PATI to Pyrazines

Back to Details
This is a "connection" page, showing publications DEBANANDA PATI has written about Pyrazines.
DEBANANDA PATI
Connection Strength
0.068
Pyrazines
  1. A phase 1 study of the proteasome inhibitor bortezomib in pediatric patients with refractory leukemia: a Children's Oncology Group study. Clin Cancer Res. 2007 Mar 01; 13(5):1516-22.
    View in: PubMed
    Score: 0.068
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.